血清バイオマーカーの世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D09371)
◆英語タイトル:Global Serum Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D09371
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年12月
◆ページ数:110
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥543,900見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、血清バイオマーカーの世界市場について調査・分析し、種類別には、肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓胆管癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他に、用途別には、病院、学術研究機関、外来手術センター、その他に区分してまとめました。調査対象企業は、Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead等です。

・レポートの概要
・グローバル成長トレンド
・血清バイオマーカーの世界市場規模
・血清バイオマーカーの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別血清バイオマーカーの価格動向
・血清バイオマーカーの種類別市場規模(肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓胆管癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他)
・血清バイオマーカーの用途別市場規模(病院、学術研究機関、外来手術センター、その他)
・血清バイオマーカーの北米市場(アメリカ、カナダ、メキシコ)
・血清バイオマーカーのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・血清バイオマーカーのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・血清バイオマーカーの中南米市場(ブラジル等)
・血清バイオマーカーの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・血清バイオマーカーの市場規模予測
・血清バイオマーカーの種類別市場予測2018-2025(肝細胞癌血清バイオマーカー、肺癌血清バイオマーカー、膵臓胆管癌血清バイオマーカー、乳癌血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他)
・血清バイオマーカーの用途別市場予測2018-2025(病院、学術研究機関、外来手術センター、その他)
・血清バイオマーカーの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・血清バイオマーカーのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・血清バイオマーカーのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・血清バイオマーカーの中南米市場予測2018-2025(ブラジル等)
・血清バイオマーカーの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.The global serum biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.
In 2018, the global Serum Biomarkers market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Serum Biomarkers.

This study researches the market size of Serum Biomarkers, presents the global Serum Biomarkers sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Serum Biomarkers in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Serum Biomarkers for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead

Market Segment by Product Type
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others

Market Segment by Application
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Serum Biomarkers status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Serum Biomarkers manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Serum Biomarkers are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Serum Biomarkers Market Size Growth Rate by Type
1.3.2 Hepatocellular Carcinoma Serum Biomarkers
1.3.3 Lung Cancer Serum Biomarkers
1.3.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
1.3.5 Breast Cancer Serum Biomarkers
1.3.6 Glioblastoma Serum Biomarkers
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Serum Biomarkers Market Share by Application (2018-2025)
1.4.2 Hospitals
1.4.3 Academic & Research Institutes
1.4.4 Ambulatory Surgical Centers
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Serum Biomarkers Market Size
2.1.1 Global Serum Biomarkers Revenue 2013-2025
2.1.2 Global Serum Biomarkers Sales 2013-2025
2.2 Serum Biomarkers Growth Rate by Regions
2.2.1 Global Serum Biomarkers Sales by Regions 2013-2018
2.2.2 Global Serum Biomarkers Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Serum Biomarkers Sales by Manufacturers
3.1.1 Serum Biomarkers Sales by Manufacturers 2013-2018
3.1.2 Serum Biomarkers Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Serum Biomarkers Revenue by Manufacturers (2013-2018)
3.2.2 Serum Biomarkers Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Serum Biomarkers Market Concentration Ratio (CR5 and HHI)
3.3 Serum Biomarkers Price by Manufacturers
3.4 Key Manufacturers Serum Biomarkers Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Serum Biomarkers Market
3.6 Key Manufacturers Serum Biomarkers Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Hepatocellular Carcinoma Serum Biomarkers Sales and Revenue (2013-2018)
4.1.2 Lung Cancer Serum Biomarkers Sales and Revenue (2013-2018)
4.1.3 Pancreatic & Biliary Tract Cancer Serum Biomarkers Sales and Revenue (2013-2018)
4.1.4 Breast Cancer Serum Biomarkers Sales and Revenue (2013-2018)
4.1.5 Glioblastoma Serum Biomarkers Sales and Revenue (2013-2018)
4.1.6 Others Sales and Revenue (2013-2018)
4.2 Global Serum Biomarkers Sales Market Share by Type
4.3 Global Serum Biomarkers Revenue Market Share by Type
4.4 Serum Biomarkers Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Serum Biomarkers Sales by Application

6 North America
6.1 North America Serum Biomarkers Breakdown Data by Company
6.2 North America Serum Biomarkers Breakdown Data by Type
6.3 North America Serum Biomarkers Breakdown Data by Application
6.4 North America Serum Biomarkers Breakdown Data by Countries
6.4.1 North America Serum Biomarkers Sales by Countries
6.4.2 North America Serum Biomarkers Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Serum Biomarkers Breakdown Data by Company
7.2 Europe Serum Biomarkers Breakdown Data by Type
7.3 Europe Serum Biomarkers Breakdown Data by Application
7.4 Europe Serum Biomarkers Breakdown Data by Countries
7.4.1 Europe Serum Biomarkers Sales by Countries
7.4.2 Europe Serum Biomarkers Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Serum Biomarkers Breakdown Data by Company
8.2 Asia Pacific Serum Biomarkers Breakdown Data by Type
8.3 Asia Pacific Serum Biomarkers Breakdown Data by Application
8.4 Asia Pacific Serum Biomarkers Breakdown Data by Countries
8.4.1 Asia Pacific Serum Biomarkers Sales by Countries
8.4.2 Asia Pacific Serum Biomarkers Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Serum Biomarkers Breakdown Data by Company
9.2 Central & South America Serum Biomarkers Breakdown Data by Type
9.3 Central & South America Serum Biomarkers Breakdown Data by Application
9.4 Central & South America Serum Biomarkers Breakdown Data by Countries
9.4.1 Central & South America Serum Biomarkers Sales by Countries
9.4.2 Central & South America Serum Biomarkers Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Serum Biomarkers Breakdown Data by Type
10.2 Middle East and Africa Serum Biomarkers Breakdown Data by Application
10.3 Middle East and Africa Serum Biomarkers Breakdown Data by Countries
10.3.1 Middle East and Africa Serum Biomarkers Sales by Countries
10.3.2 Middle East and Africa Serum Biomarkers Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Serum Biomarkers
11.1.4 Serum Biomarkers Product Introduction
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Serum Biomarkers
11.2.4 Serum Biomarkers Product Introduction
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Serum Biomarkers
11.3.4 Serum Biomarkers Product Introduction
11.3.5 Novartis Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Serum Biomarkers
11.4.4 Serum Biomarkers Product Introduction
11.4.5 Abbott Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Serum Biomarkers
11.5.4 Serum Biomarkers Product Introduction
11.5.5 BD Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Serum Biomarkers
11.6.4 Serum Biomarkers Product Introduction
11.6.5 Merck Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Serum Biomarkers
11.7.4 Serum Biomarkers Product Introduction
11.7.5 Eli Lilly Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Serum Biomarkers
11.8.4 Serum Biomarkers Product Introduction
11.8.5 Agilent Technologies Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Serum Biomarkers
11.9.4 Serum Biomarkers Product Introduction
11.9.5 Boehringer Ingelheim Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Serum Biomarkers
11.10.4 Serum Biomarkers Product Introduction
11.10.5 AstraZeneca Recent Development
11.11 Bristol-Myers Squibb
11.12 Novo Nordisk
11.13 Allergan
11.14 Gilead

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Serum Biomarkers Sales Channels
12.2.2 Serum Biomarkers Distributors
12.3 Serum Biomarkers Customers

13 Market Forecast
13.1 Global Serum Biomarkers Sales and Revenue Forecast 2018-2025
13.2 Global Serum Biomarkers Sales Forecast by Type
13.3 Global Serum Biomarkers Sales Forecast by Application
13.4 Serum Biomarkers Forecast by Regions
13.4.1 Global Serum Biomarkers Sales Forecast by Regions 2018-2025
13.4.2 Global Serum Biomarkers Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Serum Biomarkers Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Serum Biomarkers Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Serum Biomarkers Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Serum Biomarkers Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Serum Biomarkers Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Serum Biomarkers Product Picture
Table Serum Biomarkers Key Market Segments
Table Major Manufacturers Serum Biomarkers Covered in This Report
Table Global Serum Biomarkers Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Serum Biomarkers Sales Market Shar by Type 2013-2025
Figure Hepatocellular Carcinoma Serum Biomarkers Figures
Table Major Manufacturers of Hepatocellular Carcinoma Serum Biomarkers
Figure Lung Cancer Serum Biomarkers Figures
Table Major Manufacturers of Lung Cancer Serum Biomarkers
Figure Pancreatic & Biliary Tract Cancer Serum Biomarkers Figures
Table Major Manufacturers of Pancreatic & Biliary Tract Cancer Serum Biomarkers
Figure Breast Cancer Serum Biomarkers Figures
Table Major Manufacturers of Breast Cancer Serum Biomarkers
Figure Glioblastoma Serum Biomarkers Figures
Table Major Manufacturers of Glioblastoma Serum Biomarkers
Figure Others Figures
Table Major Manufacturers of Others
Table Global Serum Biomarkers Market Share by Application 2018-2025 (K Units)
Figure Hospitals Use Case
Figure Academic & Research Institutes Use Case
Figure Ambulatory Surgical Centers Use Case
Figure Others Use Case
Figure Serum Biomarkers Report Years Considered
Figure Global Serum Biomarkers Market Size 2013-2025 (Million US$)
Figure Global Serum Biomarkers Sales 2013-2018 (K Units)
Table Global Serum Biomarkers Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Serum Biomarkers Sales by Regions 2013-2018 (K Units)
Table Global Serum Biomarkers Sales Market Share by Regions 2013-2018
Figure Global Serum Biomarkers Sales Market Share by Regions 2013-2018
Figure Global Serum Biomarkers Sales Market Share by Regions in 2018
Table Global Serum Biomarkers Revenue by Regions 2013-2018 (Million US$)
Table Global Serum Biomarkers Revenue Market Share by Regions 2013-2018
Figure Global Serum Biomarkers Revenue Market Share by Regions 2013-2018
Figure Global Serum Biomarkers Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Serum Biomarkers Sales by Manufacturers (2013-2018) (K Units)
Table Global Serum Biomarkers Sales Share by Manufacturers (2013-2018)
Figure Global Serum Biomarkers Sales Share by Manufacturers in 2018
Table Serum Biomarkers Revenue by Manufacturers (2013-2018) (Million USD)
Table Serum Biomarkers Revenue Share by Manufacturers (2013-2018)
Figure Serum Biomarkers Value Share by Manufacturers in 2018
Table Global Serum Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Serum Biomarkers Price (2013-2018) (USD/Unit)
Table Key Manufacturers Serum Biomarkers Plants/Factories Distribution
Table Key Manufacturers Serum Biomarkers Area Served
Table Date of Key Manufacturers Enter into Serum Biomarkers Market
Table Key Manufacturers Serum Biomarkers Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Hepatocellular Carcinoma Serum Biomarkers Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Lung Cancer Serum Biomarkers Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Pancreatic & Biliary Tract Cancer Serum Biomarkers Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Breast Cancer Serum Biomarkers Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Glioblastoma Serum Biomarkers Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Others Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Serum Biomarkers Sales by Type (2013-2018) (K Units)
Table Global Serum Biomarkers Sales Share by Type (2013-2018)
Figure Global Serum Biomarkers Sales Market Share by Type (2013-2018)
Figure Global Serum Biomarkers Sales Market Share by Type in 2017
Table Global Serum Biomarkers Revenue by Type (2013-2018) (Million US$)
Table Global Serum Biomarkers Revenue Share by Type (2013-2018)
Figure Global Serum Biomarkers Revenue Market Share by Type (2013-2018)
Figure Global Serum Biomarkers Revenue Market Share by Type in 2017
Table Serum Biomarkers Price by Type 2013-2018 (USD/Unit)
Table Global Serum Biomarkers Sales by Application (2013-2018) (K Units)
Table Global Serum Biomarkers Sales Share by Application (2013-2018)
Figure Global Sales Serum Biomarkers Market Share by Application (2013-2018)
Figure Global Sales Serum Biomarkers Market Share by Application in 2017
Figure North America Serum Biomarkers Sales Growth Rate 2013-2018 (K Units)
Figure North America Serum Biomarkers Revenue Growth Rate 2013-2018 (Million US$)
Table North America Serum Biomarkers Sales by Company (2013-2018) (K Units)
Table North America Serum Biomarkers Sales Market Share by Company (2013-2018)
Figure North America Serum Biomarkers Sales Market Share by Company in 2018
Table North America Serum Biomarkers Sales by Type (2013-2018) (K Units)
Table North America Serum Biomarkers Sales Market Share by Type (2013-2018)
Figure North America Serum Biomarkers Market Share by Type in 2018
Table North America Serum Biomarkers Sales by Application (2013-2018) (K Units)
Table North America Serum Biomarkers Sales Market Share by Application (2013-2018)
Figure North America Serum Biomarkers Market Share by Application in 2018
Table North America Serum Biomarkers Sales by Countries (2013-2018) (K Units)
Table North America Serum Biomarkers Sales Market Share by Countries (2013-2018)
Figure 2017 North America Serum Biomarkers Sales Market Share by Countries
Table North America Serum Biomarkers Revenue by Countries (2013-2018) (Million US$)
Table North America Serum Biomarkers Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Serum Biomarkers Revenue Market Share by Countries
Figure United States Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Canada Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Europe Serum Biomarkers Sales Growth Rate 2013-2018 (K Units)
Figure Europe Serum Biomarkers Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Serum Biomarkers Sales by Company (2013-2018) (K Units)
Table Europe Serum Biomarkers Sales Market Share by Company (2013-2018)
Figure Europe Serum Biomarkers Sales Market Share by Company in 2018
Table Europe Serum Biomarkers Sales by Type (2013-2018) (K Units)
Table Europe Serum Biomarkers Sales Market Share by Type (2013-2018)
Figure 2017 Europe Serum Biomarkers Market Share by Type
Table Europe Serum Biomarkers Sales by Application (2013-2018) (K Units)
Table Europe Serum Biomarkers Sales Market Share by Application (2013-2018)
Figure 2017 Europe Serum Biomarkers Market Share by Application
Table Europe Serum Biomarkers Sales by Countries (2013-2018) (K Units)
Table Europe Serum Biomarkers Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Serum Biomarkers Sales Market Share by Countries
Table Europe Serum Biomarkers Revenue by Countries (2013-2018) (Million US$)
Table Europe Serum Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Europe Serum Biomarkers Revenue Market Share by Countries in 2018
Figure Germany Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure France Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure UK Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Italy Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Russia Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Serum Biomarkers Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Serum Biomarkers Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Serum Biomarkers Sales by Company (2013-2018) (K Units)
Table Asia Pacific Serum Biomarkers Sales Market Share by Company (2013-2018)
Figure Asia Pacific Serum Biomarkers Sales Market Share by Company in 2018
Table Asia Pacific Serum Biomarkers Sales by Type (2013-2018) (K Units)
Table Asia Pacific Serum Biomarkers Sales Market Share by Type (2013-2018)
Figure Asia Pacific Serum Biomarkers Market Share by Type in 2018
Table Asia Pacific Serum Biomarkers Sales by Application (2013-2018) (K Units)
Table Asia Pacific Serum Biomarkers Sales Market Share by Application (2013-2018)
Figure Asia Pacific Serum Biomarkers Market Share by Application in 2018
Table Asia Pacific Serum Biomarkers Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Serum Biomarkers Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Serum Biomarkers Sales Market Share by Countries
Table Asia Pacific Serum Biomarkers Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Serum Biomarkers Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Serum Biomarkers Revenue Market Share by Countries
Figure China Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure China Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Japan Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Korea Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure India Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure India Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Australia Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Serum Biomarkers Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Serum Biomarkers Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Serum Biomarkers Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Serum Biomarkers Sales by Company (2013-2018) (K Units)
Table Central & South America Serum Biomarkers Sales Market Share by Company (2013-2018)
Figure Central & South America Serum Biomarkers Sales Market Share by Company in 2018
Table Central & South America Serum Biomarkers Sales by Type (2013-2018) (K Units)
Table Central & South America Serum Biomarkers Sales Market Share by Type (2013-2018)
Figure Central & South America Serum Biomarkers Market Share by Type in 2018
Table Central & South America Serum Biomarkers Sales by Application (2013-2018) (K Units)
Table Central & South America Serum Biomarkers Sales Market Share by Application (2013-2018)
Figure Central & South America Serum Biomarkers Market Share by Application in 2018
Table Central & South America Serum Biomarkers Sales by Countries (2013-2018) (K Units)
Table Central & South America Serum Biomarkers Sales Market Share by Countries (2013-2018)
Figure Central & South America Serum Biomarkers Sales Market Share by Countries in 2018
Table Central & South America Serum Biomarkers Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Serum Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Central & South America Serum Biomarkers Revenue Market Share by Countries in 2018
Figure Brazil Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Serum Biomarkers Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Serum Biomarkers Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Serum Biomarkers Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Serum Biomarkers Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Serum Biomarkers Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Serum Biomarkers Market Share by Type
Table Middle East and Africa Serum Biomarkers Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Serum Biomarkers Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Serum Biomarkers Market Share by Application
Table Middle East and Africa Serum Biomarkers Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Serum Biomarkers Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Serum Biomarkers Sales Market Share by Countries
Table Middle East and Africa Serum Biomarkers Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Serum Biomarkers Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Serum Biomarkers Revenue Market Share by Countries
Figure GCC Countries Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Serum Biomarkers Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Serum Biomarkers Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Serum Biomarkers Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Serum Biomarkers Revenue Growth Rate (2013-2018) (K Units)
Table Roche Company Details
Table Roche Description and Business Overview
Table Roche Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Roche Serum Biomarkers Sales Growth Rate (2013-2018)
Table Roche Serum Biomarkers Sales Market Share in Global Market
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Serum Biomarkers Sales Growth Rate (2013-2018)
Table Pfizer Serum Biomarkers Sales Market Share in Global Market
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis Serum Biomarkers Sales Growth Rate (2013-2018)
Table Novartis Serum Biomarkers Sales Market Share in Global Market
Table Novartis Recent Development
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbott Serum Biomarkers Sales Growth Rate (2013-2018)
Table Abbott Serum Biomarkers Sales Market Share in Global Market
Table Abbott Recent Development
Table BD Company Details
Table BD Description and Business Overview
Table BD Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table BD Serum Biomarkers Sales Growth Rate (2013-2018)
Table BD Serum Biomarkers Sales Market Share in Global Market
Table BD Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck Serum Biomarkers Sales Growth Rate (2013-2018)
Table Merck Serum Biomarkers Sales Market Share in Global Market
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Description and Business Overview
Table Eli Lilly Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eli Lilly Serum Biomarkers Sales Growth Rate (2013-2018)
Table Eli Lilly Serum Biomarkers Sales Market Share in Global Market
Table Eli Lilly Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Description and Business Overview
Table Agilent Technologies Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Agilent Technologies Serum Biomarkers Sales Growth Rate (2013-2018)
Table Agilent Technologies Serum Biomarkers Sales Market Share in Global Market
Table Agilent Technologies Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Boehringer Ingelheim Serum Biomarkers Sales Growth Rate (2013-2018)
Table Boehringer Ingelheim Serum Biomarkers Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Serum Biomarkers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table AstraZeneca Serum Biomarkers Sales Growth Rate (2013-2018)
Table AstraZeneca Serum Biomarkers Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Novo Nordisk Company Details
Table Allergan Company Details
Table Gilead Company Details
Figure Serum Biomarkers Value Chain
Table Serum Biomarkers Distributors List
Table Serum Biomarkers Customers List
Table Global Serum Biomarkers Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Global Serum Biomarkers Revenue Forecast 2018-2025 (Million US$)
Table Global Serum Biomarkers Sales Forecast by Type 2018-2025 (K Units)
Figure Global Serum Biomarkers Sales Forecast by Type 2018-2025 (K Units)
Figure Global Serum Biomarkers Sales Market Share Forecast by Type 2018-2025
Table Global Serum Biomarkers Sales Forecast by Application 2018-2025 (K Units)
Figure Global Serum Biomarkers Sales Forecast by Application 2018-2025 (K Units)
Figure Global Serum Biomarkers Sales Market Share Forecast by Application 2018-2025
Table Global Serum Biomarkers Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Serum Biomarkers Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Serum Biomarkers Sales Market Share Forecast by Regions 2018-2025
Table Global Serum Biomarkers Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Serum Biomarkers Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Serum Biomarkers Revenue Market Share Forecast by Regions 2018-2025
Table North America Serum Biomarkers Sales Forecast by Countries 2018-2025 (K Units)
Table North America Serum Biomarkers Sales Market Share Forecast by Countries 2018-2025
Table North America Serum Biomarkers Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Serum Biomarkers Revenue Market Share Forecast by Countries 2018-2025
Figure United States Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Canada Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure MexicoSerum Biomarkers Sales Forecast 2018-2025 (K Units)
Table Europe Serum Biomarkers Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Serum Biomarkers Sales Market Share Forecast by Countries 2018-2025
Table Europe Serum Biomarkers Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Serum Biomarkers Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure France Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure UK Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Italy Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Russia Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Serum Biomarkers Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Serum Biomarkers Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Serum Biomarkers Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Serum Biomarkers Revenue Market Share Forecast by Countries 2018-2025
Figure China Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Japan Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Korea Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure India Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Australia Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Indonesia Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Thailand Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Malaysia Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Philippines Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Figure Vietnam Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Table Central & South America Serum Biomarkers Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Serum Biomarkers Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Serum Biomarkers Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Serum Biomarkers Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Serum Biomarkers Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Serum Biomarkers Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Serum Biomarkers Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Serum Biomarkers Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Serum Biomarkers Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Serum Biomarkers Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Serum Biomarkers Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Serum Biomarkers Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血清バイオマーカーの世界市場動向・分析2018-2025(Global Serum Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆